Danhong injection
Danhong injection is a pharmaceutical drug with 7 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Investigating the Clinical Benefits and Underlying Mechanisms of Danhong Injection in Modulating Mitochondrial Homeostasis Against Sepsis-Associated Myocardial Dysfunction
Danhong Injection in the Treatment of Acute Ischemic Stroke
Multi-"Omics" Research of Danhong Injection to Treat Acute Ischemic Stroke
Danhong Injection in the Treatment of Unstable Angina Pectoris
Danhong Injection in the Treatment of Chronic Stable Angina
Clinical Trials (7)
Investigating the Clinical Benefits and Underlying Mechanisms of Danhong Injection in Modulating Mitochondrial Homeostasis Against Sepsis-Associated Myocardial Dysfunction
Danhong Injection in the Treatment of Acute Ischemic Stroke
Multi-"Omics" Research of Danhong Injection to Treat Acute Ischemic Stroke
Danhong Injection in the Treatment of Unstable Angina Pectoris
Danhong Injection in the Treatment of Chronic Stable Angina
the Effect of Danhong Injection on Microcirculation in the Treatment of Patients With STEMI After the PTCA Surgery.
A Clinical Trial of Danhong Injection in Treating Acute Ischemic Stroke
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7